Statistics

Total Visits

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program48

Select a period of time:

Number of views in the range

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program27

Views

Views
October 20240
November 20244
December 20240
January 20257
February 20255
March 202511
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United Kingdom5
Spain5
United Arab Emirates2
United States1
 

Top cities views

Views
Gijón3
Oviedo2